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Since April 2017, a dengue fever outbreak has been ongo-
ing in Côte d’Ivoire. We diagnosed dengue fever (type 2 
virus) in a traveler returning to Japan from Côte d’Ivoire. 
Phylogenetic analysis revealed strain homology with the 
Burkina Faso 2016 strain. This case may serve as an alert 
to possible disease spread outside Africa.
In recent decades, dengue virus (DENV) infection has been spreading worldwide. Although in Africa the lead-
ing cause of acute febrile illness is still malaria, dengue has 
recently gained momentum (1). Dengue has been reported 
in 34 African countries, although it has probably been un-
derreported because of the lack of diagnostic testing and 
systematic surveillance in Africa (2). Four types of virus 
have been isolated; the most endemic to Africa is DENV 
type 2 (DENV-2), followed by DENV-1 (2). The first re-
ported case of DENV-1 infection occurred in a young sol-
dier from Abidjan, Côte d’Ivoire, in 1999 (3). At that time, 
no other similar cases or epidemics in Abidjan had been 
reported. In 2008, a closely related strain, DENV-3, was 
isolated from visitors to Côte d’Ivoire (4,5). In 2010, den-
gue fever was biologically confirmed for 7 patients who 
had never been in a dengue-endemic area, and DENV-3 
was confirmed by reverse transcription PCR for 4 of these 
patients (6). A prospective study in Abidjan also revealed 
that DENV-3 had been the cause of febrile illness during 
2011–2012 (7). Thus, DENV-3 may have circulated widely 
in Côte d’Ivoire, especially in Abidjan. During the 2016 
outbreak in Burkina Faso, DENV-2 infection was detected 
in 2 travelers returning from Burkina Faso to France (8). 
During August–November 2016, the World Health Organi-
zation reported 1,061 probable dengue cases and 15 deaths 
from dengue (9). We report a case of dengue fever exported 
to Japan from Abidjan in 2017.
On June 19, 2017, a man in his early 50s sought care at 
the Center Hospital of the National Center for Global Health 
and Medicine, Tokyo, Japan, for fever, chills, headache, and 
mild joint pain. In June 2013, he had traveled to Abidjan for 
business, and on June 13, 2017, he returned to Japan. He 
had been vaccinated for yellow fever. He had noticed a high 
fever in the morning and sought care the same evening. 
Physical examination revealed body temperature of 
39.3°C, mildly hyperemic conjunctiva, and a slight rash on 
his trunk. His blood biochemistry profile showed 3,640 × 109 
leukocytes/L, hemoglobin level 13.5 g/dL, and 151 × 109 
thrombocytes/L. Results of a rapid diagnostic test for malar-
ia (BinaxNOW Malaria; Alere, Waltham, MA, USA) were 
negative. A thin-coated peripheral blood smear with May-
Grünwald Giemsa stain showed no Plasmodium parasites. 
Results of a dengue rapid diagnostic test (Dengue Duo NS1 
Ag + Ab Combo; Alere) were negative for IgM and IgG but 
positive for nonstructural protein 1 antigen. Serum samples 
obtained on June 19 and 26 were sent for real-time reverse 
transcription PCR to the National Institute of Infectious Dis-
eases, Tokyo, where DENV-2 RNA was detected. 
The patient’s signs and symptoms resolved spontane-
ously in a week; his lowest thrombocyte count was 99 × 109 
thrombocytes/L. On June 19, a diagnostic test for DENV 
IgM (Dengue Virus IgM Capture ELISA; Focus Diagnos-
tics, Cypress, CA, USA) yielded negative results; however, 
on June 26, positive results indicated seroconversion. 
Phylogenetic analysis of the DENV envelope gene indi-
cated that the sequence of DENV-2 obtained from the patient 
belonged to the cosmopolitan genotype and was 99% identi-
cal with the envelope gene of DENV-2 strains from the 2016 
dengue epidemic in Burkina Faso (GenBank accession nos. 
LC206003, KY627763, and KY627762) (Figure). The se-
quence of DENV-2 from the patient also showed 97% identity 
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Figure. Comparison of dengue 
virus type 2 from a patient 
returning from Abidjan, Côte 
d’Ivoire, to Japan (arrow) with 
reference dengue virus sequences. 
Virus lineages are shown on 
right. Phylogenetic trees were 
constructed by using the neighbor-
joining method. The maximum 
composite likelihood method was 
used, and rates among sites were 
uniform. Analyses were performed 
by using MEGA6 software  
(http://megasoftware.net). Scale 
bar indicates substitutions per 
nucleotide position.
with that of the DENV-2 strains from the 1983 (accession 
no. EU056810) and 1986 (accession nos. HM234642 and 
GU131843) epidemics in Burkina Faso. Strains of DENV-2 
from the 2005 epidemic in Ghana (accession no. EU005258) 
shared 95% identity with that of the patient reported here.
Phylogenetic analysis indicated that the dengue virus 
genome sequence in this case is highly homologous with 
recent strains in Africa, especially from the 2016, 1986, and 
1983 outbreaks in Burkina Faso. Similar strains of DENV-
2 have repeatedly caused outbreaks in West Africa (8). As 
of April 2017, DENV-2 and DENV-3 have been isolated 
from patients in the ongoing outbreak in Abidjan (10). Al-
though no cases have been reported outside Abidjan, the 
case reported here may be a sentinel case, serving as an 
alert to the possibility of disease spread outside Africa.
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To the Editor: The recent etymologia article on 
Creutzfeldt-Jakob disease by Henry and Murphy (1) does 
not accurately reflect current understanding of the con-
tributions of Creutzfeldt and Jakob. Although Jakob had 
reported that Creutzfeldt’s earlier case was a “nosologi-
cally very closely connected if not identical affection” (2), 
Creutzfeldt himself later reported that “his case did not bear 
any resemblance to the cases described by Jakob” (3). As 
discussed by neuropathologist Edgar Peirson Richardson, 
Jr., in 1977, “Did Creutzfeldt and Jakob describe CJD? … 
Creutzfeldt probably did not—Jakob to the contrary not-
withstanding—and Creutzfeldt is said to have disagreed 
with the identification of his case with Jakob’s cases. Ja-
kob’s cases, on the other hand, can more readily be fitted 
into current concepts of the disease without undue strain” 
(4). In 1982, neuropathologist Colin L. Masters and pedia-
trician D. Carleton Gajdusek concurred with Richardson: 
“We agree with Richardson (1977) that Creutzfeldt’s case 
probably can be excluded from classification as a spongi-
form encephalopathy on the basis of his own clinical and 
pathological descriptions, although a specific alternative 
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